Clinical Trial Update: The Effect of G-CSF on MRD After Induction Therapy in Newly Diagnosed AML [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial investigating the effect of G-CSF on minimal residual disease after induction therapy in newly diagnosed acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Granulocyte Colony Stimulating Factor (granulocyte colony-stimulating factor (G-CSF))

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Granulocyte Colony-stimulating Factor, Minimal Residual Disease | Phase 2, Phase 3 | Status: UNKNOWN